The monkeypox testing market size is estimated to be USD 192.54 million in 2022 and is expected to witness a CAGR of 5.32% during the forecast period 2023-2033. Rising incidence of medical conditions globally, challenges in determining the primary cause of the development of the disease and government efforts to stop the virus’s spread and prevent the emergence of another pandemic are projected to drive the market growth in near future. Furthermore, increasing capacity of testing and rising acceptance of PCR test is projected to support the market growth. However, lack of awareness and high cost of testing is predicted to limit market growth are expected to restrain the market growth.

Increasing capacity of testing is expected to propel the market growth. The fact that a treatment for the disease is being researched makes it even more critical to enhance testing, making the expansion of testing capacity important. For instance, the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) began shipping orthopoxvirus tests to five private laboratory companies, including the largest reference laboratories in the nation, in June 2022 to quickly increase the capacity for monkeypox testing.

Rising acceptance of PCR test is projected to fuel the market growth. The use of PCR in numerous tests on the market has increased the acceptance of PCR diagnostics. For instance, Sonic Healthcare USA declared the availability of monkeypox testing in July 2022. Furthermore, in July 2022, Quest Diagnostics announced the countrywide availability of the lab-developed molecular diagnostic test by the organization to aid in the diagnosis of the monkeypox virus. The company also highlighted plans to introduce the CDC’s orthopoxvirus test in the first half of August.

Segmentation

 By Technology

The market is categorized into lateral flow assay, polymerase chain reaction, and others. In 2022, the polymerase chain reaction accounted for the highest revenue share due to the fast and accurate findings provided by the PCR technique. Additionally, the majority of test kits on the market use PCR-based analysis. For instance, Fulgent Genetics introduced PCR-based diagnostics for the identification of monkeypox in August 2022. Additionally, through the CDC collaboration, LabCorp developed a PCR-based monkeypox detection test in July 2022. The lateral flow assay technique segment is anticipated to grow at a profitable CAGR over the forecast period due to the rising demand for quick tests and advanced detection kits. The technology used in diagnostics is improving as a result of research and technical developments. For instance, JOYSBIO released two monkeypox test kits in August 2022 that both provide findings in under 15 minutes.

 By End User

The market is categorized into diagnostic laboratories, hospitals & clinics, and others. In the global market, the hospitals & clinics segment accounted for the largest revenue share in 2022 owing to growing adoption of testing in these healthcare institutions and the rising incidence of infection in the general population. On the other hand, the diagnostic laboratories segment is anticipated to increase at the quickest rate during the projection period owing to increasing concerns about the virus’s rapid global transmission and surge in R&D activities. For instance, the FDA released guidelines in September 2022 to encourage the development of tests for monkeypox testing. In consequence, it is predicted that this will make developing laboratory-developed tests easier.

Regional Markets

In 2022, North America region accounted for the highest revenue in the monkeypox testing market and is expected to maintain its dominance during the forecast period. This is attributed to rising incidence of monkeypox. According to the CDC, 21,274 cases from the U.S. were recorded out of a total of 56,026 cases reported worldwide. For instance, in July 2022, Labcorp announced testing for monkeypox using the U.S. CDC orthopoxvirus test, which identifies all orthopoxviruses unrelated to smallpox, including monkeypox. Labcorp was the first national laboratory to offer a monkeypox test. Europe area is also anticipated to experience significant growth over the course of the projection period. The existence of countries with the greatest prevalence and spread of the virus is responsible for the expansion. To prevent the disease’s rising prevalence, several nations are enhancing their diagnostic capabilities.

Competitor Insights

Some of the key players operating in the monkeypox testing market are Quest Diagnostics Inc., QIAGEN, Laboratory Corp. of America Holdings, Mayo Clinic Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories, Aegis Sciences Corp., Thermo Fisher Scientific, Sonic Healthcare Ltd., and BD.

To increase their market position, key companies in this market are using a variety of strategies, such as alliances through mergers and acquisitions, geographic expansion, and strategic collaborations.

• For instance, CerTest Biotec and BD (Becton, Dickinson and Company) worked together in June 2022 to create a molecular diagnostic test for the monkeypox virus. With FDA authorisation for emergency usage, new tests are being released. For instance, the Quest Diagnostics monkeypox test was given EUA certification in September 2022.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including technology and end user from 2022 to 2033.

Report Scope:

Segmentation: Monkeypox Testing Market Report 2022 – 2033

Technology (Revenue, USD Million), 2022 – 2033

• Lateral Flow Assay
• Polymerase Chain Reaction
• Others

End user (Revenue, USD Million), 2022 – 2033

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA